We are live on
!
Find out more
CEP
Chicago Equity Partners Portfolio holdings
AUM
$993M
1-Year Est. Return
6.42%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
-6.42%
3 Year Est. Return
+34.83%
5 Year Est. Return
+90.28%
10 Year Est. Return
–
AUM
$3.63B
AUM Growth
+$297M
(+8.9%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
16.99%
Holding
521
New
107
Increased
188
Reduced
135
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.6M |
| 2 |
Walt Disney
DIS
|
+$40.3M |
| 3 |
Pitney Bowes
PBI
|
+$34.5M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$31.8M |
| 5 |
Bank of America
BAC
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$41.7M |
| 2 |
STJ
St Jude Medical
STJ
|
+$28.9M |
| 3 |
Citigroup
C
|
+$27.7M |
| 4 |
AES
AES
|
+$22.8M |
| 5 |
Netflix
NFLX
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.21% |
| 2 | Industrials | 13.73% |
| 3 | Healthcare | 12.86% |
| 4 | Technology | 10.89% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Jazz Pharmaceuticals
JAZZ
$16.2B
| $263K | 0.01% |
1,900
+25
| +1% | +$3.76K |
|
|
SCTY
402
DELISTED
SolarCity Corporation
SCTY
| $263K | 0.01% |
+4,200
| New | +$303K |
|
403
The Greenbrier Companies
GBX
$1.59B
| $261K | 0.01% |
+5,725
| New | +$226K |
|
404
Jack in the Box
JACK
$306M
| $260K | 0.01% |
+4,425
| New | +$241K |
|
|
PDLI
405
DELISTED
PDL BioPharma, Inc.
PDLI
| $260K | 0.01% |
31,375
+425
| +1% | +$3.64K |
|
406
Stratasys
SSYS
$693M
| $256K | 0.01% |
2,420
+200
| +9% | +$23.9K |
|
407
Ubiquiti
UI
$32B
| $252K | 0.01% |
5,550
| – | – |
|
408
Workday
WDAY
$39B
| $251K | 0.01% |
2,750
-25,525
| -90% | -$2.43M |
|
|
PCP
409
DELISTED
PRECISION CASTPARTS CORP
PCP
| $251K | 0.01% |
995
-100
| -9% | -$25.9K |
|
410
Aaon
AAON
$7.77B
| $250K | 0.01% |
20,221
-1,350
| -6% | -$17.9K |
|
411
Chemed
CHE
$6.81B
| $248K | 0.01% |
+2,775
| New | +$226K |
|
|
WNR
412
DELISTED
Western Refining Inc
WNR
| $247K | 0.01% |
6,400
+1,200
| +23% | +$47.1K |
|
413
Herbalife
HLF
$1.29B
| $241K | 0.01% |
+8,450
| New | +$279K |
|
414
Hershey
HSY
$37.2B
| $240K | 0.01% |
2,300
-4,850
| -68% | -$496K |
|
|
CWEI
415
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $240K | 0.01% |
+2,125
| New | +$181K |
|
416
Lakeland Financial Corp
LKFN
$1.59B
| $237K | 0.01% |
+8,850
| New | +$225K |
|
417
Idacorp
IDA
$8.32B
| $235K | 0.01% |
+4,250
| New | +$228K |
|
418
Sysco
SYY
$41.2B
| $232K | 0.01% |
6,435
-7,910
| -55% | -$284K |
|
|
UCTT
419
Ultra Clean Holdings
UCTT
$3.44B
| $229K | 0.01% |
+17,475
| New | +$218K |
|
420
Quest Diagnostics
DGX
$26.3B
| $225K | 0.01% |
+3,900
| New | +$209K |
|
421
IBM
IBM
$210B
| $225K | 0.01% |
1,225
-89,114
| -99% | -$15.7M |
|
422
Asbury Automotive
ABG
$4.31B
| $219K | 0.01% |
+3,975
| New | +$203K |
|
|
SWFT
423
DELISTED
Swift Transportation Company
SWFT
| $218K | 0.01% |
8,825
-1,075
| -11% | -$24.9K |
|
|
STI
424
DELISTED
SunTrust Banks, Inc.
STI
| $217K | 0.01% |
5,475
| – | – |
|
|
APC
425
DELISTED
Anadarko Petroleum
APC
| $214K | 0.01% |
2,525
-9,450
| -79% | -$775K |
|
Similar funds
EA
OWD
AVC
ECP
BAC
PP
WWM
JA
Chicago Equity Partners's Q1 2014 Portfolio in Review
As of Q1 2014, Chicago Equity Partners held 521 positions worth $3.63B, up 8.9% from $3.33B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Chicago Equity Partners deployed $186M of net new capital in Q1 2014, opening 107 new positions and adding to 188 existing holdings. Its largest new stake was Gilead Sciences: 530,865 shares worth $37.6M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $41.7M trimmed.
- Chicago Equity Partners's largest Q1 2014 buy was Gilead Sciences: 530,865 shares worth $37.6M.
- Chicago Equity Partners added most to Pitney Bowes in Q1 2014, an estimated $34.5M increase.
- Chicago Equity Partners's biggest Q1 2014 reduction was Amgen, cutting an estimated $41.7M.
- Chicago Equity Partners fully exited AES in Q1 2014, selling an estimated $22.8M.
- Chicago Equity Partners's ten largest holdings make up 17% of its $3.63B portfolio in Q1 2014.
- Chicago Equity Partners opened 107 new positions and closed 77 in Q1 2014.
- Chicago Equity Partners's portfolio value rose 8.9% quarter-over-quarter to $3.63B.
Based on Chicago Equity Partners's 13F filing for Q1 2014, filed 2 May 2014.